|
| 36892581 | Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma. | Clin Cancer Res | 2023 |
| 37750994 | Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis. | Dermatol Ther (Heidelb) | 2023 |
| 36892581 | Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma. | Clin Cancer Res | 2023 |
| 37142763 | Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. | Nat Med | 2023 |
| 36730670 | Vaccination-Based Immunoprevention of Colorectal Tumors: A Primer for the Clinician. | J Clin Gastroenterol | 2023 |
| 36529811 | Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. | Paediatr Drugs | 2023 |
| 37511077 | Translating Molecular Biology Discoveries to Develop Targeted Cancer Interception in Barrett's Esophagus. | Int J Mol Sci | 2023 |
| 37480432 | Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years. | Dermatol Ther (Heidelb) | 2023 |
| 36723913 | Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials. | JAMA Dermatol | 2023 |
| 37750994 | Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis. | Dermatol Ther (Heidelb) | 2023 |
| 37480432 | Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years. | Dermatol Ther (Heidelb) | 2023 |
| 37511077 | Translating Molecular Biology Discoveries to Develop Targeted Cancer Interception in Barrett's Esophagus. | Int J Mol Sci | 2023 |
| 37142763 | Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. | Nat Med | 2023 |
| 36723913 | Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials. | JAMA Dermatol | 2023 |
| 36730670 | Vaccination-Based Immunoprevention of Colorectal Tumors: A Primer for the Clinician. | J Clin Gastroenterol | 2023 |
| 36529811 | Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. | Paediatr Drugs | 2023 |
| 35083774 | Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data. | Pediatr Dermatol | 2022 |
| 36047056 | Can a Banana a Day Keep the Cancer Away in Patients with Lynch Syndrome? | Cancer Prev Res (Phila) | 2022 |
| 35380457 | A human Barrett's esophagus organoid system reveals epithelial-mesenchymal plasticity induced by acid and bile salts. | Am J Physiol Gastrointest Liver Physiol | 2022 |
| 36087100 | Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis. | Am J Gastroenterol | 2022 |
| 35567671 | Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE). | Am J Clin Dermatol | 2022 |
| 37180617 | Correlation of Fetal Anterior Abdominal Wall Thickness and Other Standard Biometric Ultrasound Measurements to Predict Fetal Macrosomia in Gestational Diabetes. | J Med Ultrasound | 2022 |
| 34969709 | Pre-operative Carboplatin/Paclitaxel <i>Versus</i> 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer. | Anticancer Res | 2022 |
| 35083774 | Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data. | Pediatr Dermatol | 2022 |
| 35380457 | A human Barrett's esophagus organoid system reveals epithelial-mesenchymal plasticity induced by acid and bile salts. | Am J Physiol Gastrointest Liver Physiol | 2022 |
| 35567671 | Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE). | Am J Clin Dermatol | 2022 |
| 37180617 | Correlation of Fetal Anterior Abdominal Wall Thickness and Other Standard Biometric Ultrasound Measurements to Predict Fetal Macrosomia in Gestational Diabetes. | J Med Ultrasound | 2022 |
| 36087100 | Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis. | Am J Gastroenterol | 2022 |
| 36047056 | Can a Banana a Day Keep the Cancer Away in Patients with Lynch Syndrome? | Cancer Prev Res (Phila) | 2022 |
| 34969709 | Pre-operative Carboplatin/Paclitaxel <i>Versus</i> 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer. | Anticancer Res | 2022 |
| 32379085 | Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women. | J Clin Gastroenterol | 2021 |
| 32379085 | Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women. | J Clin Gastroenterol | 2021 |
| 32277372 | Role of Extracellular Vesicles in the Diagnosis and Pathogenesis of Barrett's Esophagus: A Mini-Review. | Dig Dis Sci | 2021 |
| 34272113 | Does closed treatment of paediatric mandibular condyle fractures result in restitutional remodelling? | Br J Oral Maxillofac Surg | 2021 |
| 33883421 | How extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma. | Curr Opin Gastroenterol | 2021 |
| 33495575 | Forkhead box F1 induces columnar phenotype and epithelial-to-mesenchymal transition in esophageal squamous cells to initiate Barrett's like metaplasia. | Lab Invest | 2021 |
| 32969489 | Dupilumab provides favourable long-term safety and efficacy in children aged â¿¥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study. | Br J Dermatol | 2021 |
| 32893393 | A phase 2, open-label study of single-dose dupilumab in children aged 6Â months to <6Â years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy. | J Eur Acad Dermatol Venereol | 2021 |
| 34462864 | Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial. | Paediatr Drugs | 2021 |
| 34403452 | Colonoscopy polyp detection and classification: Dataset creation and comparative evaluations. | PLoS One | 2021 |
| 34396449 | Advances in immune therapies for the treatment of microsatellite instabilityâ¿¿high/deficient mismatch repair metastatic colorectal cancer (Review). | Int J Oncol | 2021 |
| 34427891 | Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6Â Years of Age and Older. | Dermatol Ther (Heidelb) | 2021 |
| 33883421 | How extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma. | Curr Opin Gastroenterol | 2021 |
| 33495575 | Forkhead box F1 induces columnar phenotype and epithelial-to-mesenchymal transition in esophageal squamous cells to initiate Barrett's like metaplasia. | Lab Invest | 2021 |
| 34403452 | Colonoscopy polyp detection and classification: Dataset creation and comparative evaluations. | PLoS One | 2021 |
| 34462864 | Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial. | Paediatr Drugs | 2021 |
| 34427891 | Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6Â Years of Age and Older. | Dermatol Ther (Heidelb) | 2021 |
| 34396449 | Advances in immune therapies for the treatment of microsatellite instabilityâ¿¿high/deficient mismatch repair metastatic colorectal cancer (Review). | Int J Oncol | 2021 |
| 34272113 | Does closed treatment of paediatric mandibular condyle fractures result in restitutional remodelling? | Br J Oral Maxillofac Surg | 2021 |
| 32969489 | Dupilumab provides favourable long-term safety and efficacy in children aged â¿¥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study. | Br J Dermatol | 2021 |